Research / NVT / Fundamental state Inspectable configuration
State dimensions Filing 0001628280-26-051428 General Corporate
Debt relative to revenue 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
101.43% · OPTIONAL · VALID
Capex intensity 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.46% · OPTIONAL · VALID
Operating cash generation 45th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
12.47% · OPTIONAL · VALID
Share-count growth 100th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.shares_outstanding
0.57% · CORE · VALID
Revenue growth 95th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
52.77% · CORE · VALID
Inventory pressure 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
35.51% · OPTIONAL · VALID
Gross margin 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
37.93% · CORE · VALID
Operating margin 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
20.44% · CORE · VALID
R&D intensity 0th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.67% · OPTIONAL · VALID
SBC intensity 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.46% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Sep 30, 2021 10/10 normalized Level 3 Dec 31, 2021 10/10 normalized Level 3 Mar 31, 2022 10/10 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 10/10 normalized Level 3 Mar 31, 2023 10/10 normalized Level 3 Jun 30, 2023 10/10 normalized Level 3 Sep 30, 2023 10/10 normalized Level 3 Dec 31, 2023 10/10 normalized Level 3 Mar 31, 2024 10/10 normalized Level 3 Jun 30, 2024 10/10 normalized Level 3 Sep 30, 2024 10/10 normalized Level 3 Dec 31, 2024 10/10 normalized Level 3 Mar 31, 2025 10/10 normalized Level 3 Jun 30, 2025 10/10 normalized Level 3 Sep 30, 2025 10/10 normalized Level 3 Dec 31, 2025 10/10 normalized Level 3 Mar 31, 2026 10/10 normalized Level 3 Jun 30, 2026 10/10 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 125.34%
Current 101.43%
Delta -23.90% Capex Intensity Decreased
Previous 2.91%
Current 1.46%
Delta -1.45% Cash Generation Increased
Previous 6.86%
Current 12.47%
Delta 5.61% Dilution Increased
Previous -1.77%
Current 0.57%
Delta 2.34% Growth Decreased
Previous 53.47%
Current 52.77%
Delta -0.70% Inventory Pressure Decreased
Previous 41.22%
Current 35.51%
Delta -5.72% Margin Increased
Previous 35.88%
Current 37.93%
Delta 2.05% Profitability Increased
Previous 15.76%
Current 20.44%
Delta 4.68% R And D Intensity Decreased
Previous 1.83%
Current 1.67%
Delta -0.16% Sbc Intensity Decreased
Previous 1.32%
Current 0.46%
Delta -0.87% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Dec 31, 2021
Similarity 74%
Compared 10 dimensions
Coverage 100% Growth 13.2 · Margin 3.3 · Dilution 45.5 · Profitability 46.7 · Sbc Intensity 28.3 · Capex Intensity 30.0 · Cash Generation 5.0 · R And D Intensity 6.7 · Inventory Pressure 5.0 · Balance Sheet Leverage 25.0 Mar 31, 2021
Similarity 72%
Compared 10 dimensions
Coverage 100% Growth 5.0 · Margin 5.0 · Dilution 37.5 · Profitability 33.3 · Sbc Intensity 5.0 · Capex Intensity 56.7 · Cash Generation 11.7 · R And D Intensity 33.3 · Inventory Pressure 25.0 · Balance Sheet Leverage 16.7 Sep 30, 2022
Similarity 69%
Compared 7 dimensions
Coverage 70% Growth 30.7 · Margin 20.0 · Dilution 35.7 · Profitability 5.6 · R And D Intensity 5.6 · Inventory Pressure 63.9 · Balance Sheet Leverage 2.8 Dec 31, 2023
Similarity 56%
Compared 10 dimensions
Coverage 100% Growth 37.1 · Margin 60.0 · Dilution 10.5 · Profitability 10.0 · Sbc Intensity 45.0 · Capex Intensity 80.0 · Cash Generation 20.0 · R And D Intensity 75.0 · Inventory Pressure 0.0 · Balance Sheet Leverage 0.0 Sep 30, 2025
Similarity 53%
Compared 10 dimensions
Coverage 100% Growth 5.0 · Margin 20.0 · Dilution 95.0 · Profitability 55.0 · Sbc Intensity 80.0 · Capex Intensity 35.0 · Cash Generation 40.0 · R And D Intensity 5.0 · Inventory Pressure 5.0 · Balance Sheet Leverage 25.0 Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.